6-144186653-T-G
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_003764.4(STX11):āc.26T>Gā(p.Leu9Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000764 in 1,614,122 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003764.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STX11 | NM_003764.4 | c.26T>G | p.Leu9Arg | missense_variant | 2/2 | ENST00000367568.5 | NP_003755.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STX11 | ENST00000367568.5 | c.26T>G | p.Leu9Arg | missense_variant | 2/2 | 1 | NM_003764.4 | ENSP00000356540 | P1 | |
STX11 | ENST00000698355.1 | c.26T>G | p.Leu9Arg | missense_variant | 3/3 | ENSP00000513678 | P1 | |||
STX11 | ENST00000698356.1 | c.26T>G | p.Leu9Arg | missense_variant | 4/4 | ENSP00000513679 | P1 | |||
STX11 | ENST00000698357.1 | c.26T>G | p.Leu9Arg | missense_variant | 2/2 | ENSP00000513680 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000696 AC: 106AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000852 AC: 214AN: 251302Hom.: 0 AF XY: 0.000817 AC XY: 111AN XY: 135906
GnomAD4 exome AF: 0.000771 AC: 1127AN: 1461800Hom.: 2 Cov.: 31 AF XY: 0.000784 AC XY: 570AN XY: 727202
GnomAD4 genome AF: 0.000696 AC: 106AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.000685 AC XY: 51AN XY: 74494
ClinVar
Submissions by phenotype
Familial hemophagocytic lymphohistiocytosis 4 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | STX11: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 03, 2019 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.26T>G (p.L9R) alteration is located in exon 2 (coding exon 1) of the STX11 gene. This alteration results from a T to G substitution at nucleotide position 26, causing the leucine (L) at amino acid position 9 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at